Children given mRNA COVID-19 vaccines showed dangerous immune system alterations one year later

A new study shows that children between the ages of five and 11 who were given two doses of Pfizer’s Wuhan coronavirus (COVID-19) mRNA vaccines had raised levels of antibodies that indicate an altered immune system response a year after getting the jab.

The study, which was published in The Pediatric Infectious Disease Journal and conducted by German researchers, examined blood samples taken from 14 healthy children on the day they received their first dose of the vaccine, as well as at the one-month mark and one year after getting their second dose. At that point, the levels of immunoglobulin (Ig) G4 antibodies in their blood were elevated, which suggests that their immune system actually changed its response mechanism.

Although previous studies have seen this same phenomenon in adults, the new study is believed to be the first to demonstrate that it also occurs in children.

In their report, the researchers cautioned: “IgG4 responses should gain more attention in health and disease, especially in the context of mRNA vaccination. Understanding the unusual mechanism triggering IgG4 production is crucial as more mRNA vaccines are currently under development and could hit the global market soon.”

Children’s Health Defense Chief Scientific Officer Dr. Brian Hooker said that the study’s conclusion is worrying given the connection between raised IgG4 levels and IgG4-related disease, which is a “multi-organ, fibro-inflammatory condition that usually involves the pancreas, kidneys or salivary glands but could involve any other organ.”

He notes that as much as 80% of people who have the disease have high levels of these antibodies, and although it can be treated, it is associated with chronic underlying autoimmune conditions that often need lifelong treatment.

Another concerning aspect of this finding is the fact that the human body’s ability to fight off cancer can be compromised when the immune system has elevated IgG4 antibodies.

In addition, a 2022 study revealed that people who have IgG4-related diseased may have a higher risk of several types of cancer, particularly lymphoma and pancreatic cancer, when compared to the general population.

The potential for increased levels of these antibodies due to COVID-19 vaccines to harm the immune system has long been a concern among researchers.

Risk of myocarditis is 620% higher after mRNA COVID-19 vaccines, study shows

Another way that COVID-19 vaccines are damaging children’s health is by causing heart problems such as myocarditis and pericarditis. This has been flagged since the vaccines were first rolled out and increases in these conditions were observed following vaccination. (Related: Heart failure surge among children linked to COVID-19 vaccines.)

Recently, a peer-reviewed study of more than nine million South Koreans found a remarkable 620% increase in the risk of myocarditis and a 175% rise in the risk of pericarditis after receiving the vaccine. Their findings came after following 4.5 million individuals for an average of 15 months after getting the jab.

Meanwhile, a study carried out in Thailand during the country’s adolescent COVID-19 vaccine campaign found a “stunning” association between the Pfizer shot and myocarditis.

The study, which involved more than 300 teens aged 13 to 18, found that 18% had abnormal electrocardiograms following their second dose, with 3.5% of males developing myocarditis or myopericarditis and one being admitted to the ICU for related heart problems.

Unfortunately, this could be just the beginning of the studies showing the dangerous long-term effects of the shots as many problems will only become apparent with time. These studies are a reminder of precisely why so many people feared getting experimental vaccines, especially for children who are at a delicate time in their development.

Sources for this article include:

ChildrensHealthDefense.org 1

Journals.LWW.com

ChildrensHealthDefense.org 2

ChildrensHealthDefense.org 3

NaturalNews.com